+ Site Statistics
References:
52,572,879
Abstracts:
28,705,754
PMIDs:
27,750,366
DOIs:
25,464,004
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A comparison of montreal cognitive assessment between patients with visual hallucinations and without visual hallucinations in Parkinson's disease



A comparison of montreal cognitive assessment between patients with visual hallucinations and without visual hallucinations in Parkinson's disease



Clinical Neurology and Neurosurgery 130: 98-100



Visual hallucination (VH) is closely associated with cognitive impairment in Parkinson's disease (PD). The aim of this study is to analyze the domain of cognitive impairment related to the VH by analyzing cognition in PD. Twenty-six of 58 patients had VH (PD-VH), whereas 32 patients had no hallucinations (PD-NH); patients assigned to the PD-VH on the basis of having at least one VH per week for one month before participation in the study. All of the patients were administered the Montreal Cognitive Assessment-Korean test (MoCA-K). We analyzed the differences in cognition between PD-VH and PD-NH. The Hoehn-Yahr (HY) stage and the Beck Depression Inventory version I (BDI) scores in PD-VH were significantly different from those in PD-NH. After adjusting for the HY stage and BDI, the language domain of the MoCA-K cognitive domains presents a significant difference between PD-VH and PD-NH. Sentence processing and naming as the composition of the language domain in the MoCA-K have been associated in common with posterior cortical dysfunction. Although our result shows that the language domain of MoCA-K is sensitive to cognitive deficit in PD-VH patients, it needs further neuroimaging analysis for certifying the relationship between language impairment and posterior cortical deficit as the pathophysiology of PD-VH.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057057141

Download citation: RISBibTeXText

PMID: 25596487

DOI: 10.1016/j.clineuro.2014.12.022


Related references

Cognitive changes in Parkinson's disease patients with visual hallucinations. Dementia and Geriatric Cognitive Disorders 23(5): 281-288, 2007

Cognitive correlates of visual hallucinations in non-demented Parkinson's disease patients. Parkinsonism and Related Disorders 19(9): 795-799, 2014

"String Hallucinations": Multimodal Tactile and Visual Hallucinations in Parkinson's Disease. Movement Disorders Clinical Practice 3(2): 180-183, 2019

Informant- and Self-Appraisals on the Psychosis and Hallucinations Questionnaire (PsycH-Q) Enhances Detection of Visual Hallucinations in Parkinson's Disease. Movement Disorders Clinical Practice 5(6): 607-613, 2019

The Relationship Between Serotonin-2A Receptor and Cognitive Functions in Nondemented Parkinson's Disease Patients with Visual Hallucinations. Movement Disorders Clinical Practice 4(5): 698-709, 2017

Visual object recognition and attention in Parkinson's disease patients with visual hallucinations. Movement Disorders 23(13): 1906-1912, 2008

Feasibility of a web-based survey of hallucinations and assessment of visual function in patients with Parkinson's disease. Interactive Journal of Medical Research 3(1): E1, 2014

Preliminary FMRI evidence of visual system dysfunction in Parkinson's disease patients with visual hallucinations. Journal of Neuropsychiatry and Clinical Neurosciences 18(3): 402-404, 2006

Visual hallucinations and associated factors in Chinese patients with Parkinson's disease: roles of RBD and visual pathway deficit. Parkinsonism and Related Disorders 16(10): 695-696, 2011

Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations. Brain 132(Pt 11): 2980-2993, 2010

The effects of apomorphine on visual perception in patients with Parkinson disease and visual hallucinations: a pilot study. Clinical Neuropharmacology 32(5): 266-268, 2010

Visual hallucinations and cognitive impairment in Parkinson's disease. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 40(5): 657-662, 2013

Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment. Human Brain Mapping 37(3): 968-977, 2016

Visual hallucinations on eye closure associated with atropine toxicity. A neurological analysis and comparison with other visual hallucinations. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 18(1): 18-27, 1991

High-Order Visual Processing, Visual Symptoms, and Visual Hallucinations: A Possible Symptomatic Progression of Parkinson's Disease. Frontiers in Neurology 9: 999-999, 2018